{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T15:32:28Z","timestamp":1784043148799,"version":"3.55.0"},"reference-count":14,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2025,4,16]],"date-time":"2025-04-16T00:00:00Z","timestamp":1744761600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,4,16]],"date-time":"2025-04-16T00:00:00Z","timestamp":1744761600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100002701","name":"Ministry of Education","doi-asserted-by":"publisher","award":["RS-2023-00244520"],"award-info":[{"award-number":["RS-2023-00244520"]}],"id":[{"id":"10.13039\/501100002701","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Jpn J Radiol"],"published-print":{"date-parts":[[2025,9]]},"DOI":"10.1007\/s11604-025-01785-7","type":"journal-article","created":{"date-parts":[[2025,4,16]],"date-time":"2025-04-16T02:56:05Z","timestamp":1744772165000},"page":"1498-1508","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Application of LI-RADS CT\/MRI Radiation Treatment Response Assessment Version 2024: a study after transarterial radioembolization for hepatocellular carcinoma"],"prefix":"10.1007","volume":"43","author":[{"given":"Jaeseung","family":"Shin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6893-3136","authenticated-orcid":false,"given":"Sunyoung","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ja Kyung","family":"Yoon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyowon","family":"Gu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sun-Young","family":"Baek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dong-Ho","family":"Hyun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gyoung Min","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jong Yun","family":"Won","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,4,16]]},"reference":[{"issue":"3","key":"1785_CR1","first-page":"209","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global Cancer Statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71(3):209\u201349.","journal-title":"CA Cancer J Clin"},{"issue":"8","key":"1785_CR2","doi-asserted-by":"publisher","first-page":"1742","DOI":"10.1002\/cncr.21359","volume":"104","author":"A Gennari","year":"2005","unstructured":"Gennari A, Conte P, Rosso R, Orlandini C, Bruzzi P. Survival of metastatic breast carcinoma patients over a 20-year period: a retrospective analysis based on individual patient data from six consecutive studies. Cancer. 2005;104(8):1742\u201350.","journal-title":"Cancer"},{"issue":"17","key":"1785_CR3","doi-asserted-by":"publisher","first-page":"2439","DOI":"10.1016\/S0959-8049(03)00601-4","volume":"39","author":"G Atalay","year":"2003","unstructured":"Atalay G, Biganzoli L, Renard F, Paridaens R, Cufer T, Coleman R, et al. Clinical outcome of breast cancer patients with liver metastases alone in the anthracycline-taxane era: a retrospective analysis of two prospective, randomised metastatic breast cancer trials. Eur J Cancer. 2003;39(17):2439\u201349.","journal-title":"Eur J Cancer"},{"issue":"1","key":"1785_CR4","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3350\/cmh.2023.0125","volume":"30","author":"K Sankar","year":"2024","unstructured":"Sankar K, Gong J, Osipov A, Miles SA, Kosari K, Nissen NN, et al. Recent advances in the management of hepatocellular carcinoma. Clin Mol Hepatol. 2024;30(1):1\u201315.","journal-title":"Clin Mol Hepatol"},{"issue":"7","key":"1785_CR5","doi-asserted-by":"publisher","first-page":"1624","DOI":"10.1002\/cncr.21778","volume":"106","author":"KR Hess","year":"2006","unstructured":"Hess KR, Varadhachary GR, Taylor SH, Wei W, Raber MN, Lenzi R, et al. Metastatic patterns in adenocarcinoma. Cancer. 2006;106(7):1624\u201333.","journal-title":"Cancer"},{"issue":"6","key":"1785_CR6","doi-asserted-by":"publisher","first-page":"1641","DOI":"10.1002\/jmri.28659","volume":"57","author":"R Patel","year":"2023","unstructured":"Patel R, Aslam A, Parikh ND, Mervak B, Mubarak E, Higgins L, et al. Updates on LI-RADS treatment response criteria for hepatocellular carcinoma: focusing on MRI. J Magn Reson Imaging. 2023;57(6):1641\u201354.","journal-title":"J Magn Reson Imaging"},{"issue":"3","key":"1785_CR7","doi-asserted-by":"publisher","first-page":"704","DOI":"10.1016\/j.ijrobp.2021.10.006","volume":"112","author":"M Mendiratta-Lala","year":"2022","unstructured":"Mendiratta-Lala M, Aslam A, Maturen KE, Westerhoff M, Maurino C, Parikh ND, et al. LI-RADS treatment response algorithm: performance and diagnostic accuracy with radiologic-pathologic explant correlation in patients with SBRT-treated hepatocellular carcinoma. Int J Radiat Oncol Biol Phys. 2022;112(3):704\u201314.","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"3","key":"1785_CR8","doi-asserted-by":"publisher","first-page":"554","DOI":"10.1148\/radiol.2020192797","volume":"296","author":"S Park","year":"2020","unstructured":"Park S, Joo I, Lee DH, Bae JS, Yoo J, Kim SW, et al. Diagnostic performance of LI-RADS treatment response algorithm for hepatocellular carcinoma: adding ancillary features to MRI compared with enhancement patterns at CT and MRI. Radiology. 2020;296(3):554\u201361.","journal-title":"Radiology"},{"issue":"3","key":"1785_CR9","doi-asserted-by":"publisher","first-page":"484","DOI":"10.2214\/AJR.21.26677","volume":"218","author":"YY Kim","year":"2022","unstructured":"Kim YY, Kim MJ, Yoon JK, Shin J, Roh YH. Incorporation of ancillary MRI features into the LI-RADS treatment response algorithm: impact on diagnostic performance after locoregional treatment of hepatocellular carcinoma. AJR Am J Roentgenol. 2022;218(3):484\u201393.","journal-title":"AJR Am J Roentgenol"},{"issue":"1","key":"1785_CR10","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1002\/jmri.21818","volume":"30","author":"JS Yu","year":"2009","unstructured":"Yu JS, Kim JH, Chung JJ, Kim KW. Added value of diffusion-weighted imaging in the MRI assessment of perilesional tumor recurrence after chemoembolization of hepatocellular carcinomas. J Magn Reson Imaging. 2009;30(1):153\u201360.","journal-title":"J Magn Reson Imaging"},{"issue":"17","key":"1785_CR11","doi-asserted-by":"publisher","first-page":"4432","DOI":"10.3390\/cancers13174432","volume":"13","author":"YJ Huh","year":"2021","unstructured":"Huh YJ, Kim DH, Kim B, Choi JI, Rha SE. Per-feature accuracy of liver imaging reporting and data system locoregional treatment response algorithm: a systematic review and meta-analysis. Cancers (Basel). 2021;13(17):4432.","journal-title":"Cancers (Basel)."},{"issue":"17","key":"1785_CR12","doi-asserted-by":"publisher","first-page":"4432","DOI":"10.3390\/cancers13174432","volume":"13","author":"YJ Huh","year":"2021","unstructured":"Huh YJ, Kim DH, Kim B, Choi JI, Rha SE. Per-feature accuracy of liver imaging reporting and data system locoregional treatment response algorithm: a systematic review and meta-analysis. Cancers (Basel). 2021;13(17):4432.","journal-title":"Cancers (Basel)"},{"key":"1785_CR13","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejrad.2020.109351","volume":"133","author":"MJ King","year":"2020","unstructured":"King MJ, Tong A, Dane B, Huang C, Zhan C, Shanbhogue K. Response assessment of hepatocellular carcinoma treated with yttrium-90 radioembolization: inter-reader variability, comparison with 3D quantitative approach, and role in the prediction of clinical outcomes. Eur J Radiol. 2020;133: 109351.","journal-title":"Eur J Radiol"},{"issue":"9","key":"1785_CR14","doi-asserted-by":"publisher","first-page":"6493","DOI":"10.1007\/s00330-022-08732-4","volume":"32","author":"N Vietti Violi","year":"2022","unstructured":"Vietti Violi N, Gnerre J, Law A, Hectors S, Bane O, Doucette J, et al. Assessment of HCC response to Yttrium-90 radioembolization with gadoxetate disodium MRI: correlation with histopathology. Eur Radiol. 2022;32(9):6493\u2013503.","journal-title":"Eur Radiol"}],"container-title":["Japanese Journal of Radiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11604-025-01785-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11604-025-01785-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11604-025-01785-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,6]],"date-time":"2025-09-06T11:06:08Z","timestamp":1757156768000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11604-025-01785-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,16]]},"references-count":14,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2025,9]]}},"alternative-id":["1785"],"URL":"https:\/\/doi.org\/10.1007\/s11604-025-01785-7","relation":{},"ISSN":["1867-1071","1867-108X"],"issn-type":[{"value":"1867-1071","type":"print"},{"value":"1867-108X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,16]]},"assertion":[{"value":"19 December 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 April 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 April 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors have no conflicts of interest to declare.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The IRB of Samsung medical center and Severance hospital approved this study. Due to the retrospective nature of the study, the need for informed consent was waived.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}}]}}